November 20, 2012
The now-defunct Healogica app.
Clinical trials are a clear area where mobile engagement and big data have serious potential, but it's still a largely untapped use case. There have been a lot of stories recently about the opportunities in that space, but also on the challenges companies have encountered in implementing them. At least one abandoned study and one failed company can attest to those...
July 9, 2012
At the DIA Annual Meeting in Philadelphia last month, Vodafone and Exco InTouch announced a deal that sees Vodafone launching a new mobile-enabled clinical trial offering that leverages Exco's patient reported outcomes software for mobile phones. Exco made headlines last year when it inked a deal with pharmaceutical company Pfizer to determine how effective mobile-enabled clinical trials could be...
January 19, 2012
In recent months a number of deals, acquisitions, service and product launches have led to a growing discussion around the mobile health opportunities for pharma companies. There seem to be three big ones vying for the top.
Is it adding connectivity to clinical trials?
Earlier this month research analyst firm Cutting Edge Information (CEI) published a report that suggested pharma companies look...
October 3, 2011
London-based Exco InTouch, which is providing Pfizer with the mobile clinical trial technology its using in its REMOTE study, has secured about $4.67 million from Scottish Equity Partners (SEP). Exco plans to use the funds to expand and take advantage of the "significant growth opportunities" in the emerging mobile patient communication market, the company's press release stated.
Exco claims to...
June 28, 2011
Pfizer has tapped Exco InTouch to use its eDiary technology for the mobile-enabled Participatory Patient-Centered (PPC) clinical trial that we first reported on earlier this month. At the time Pfizer called the trial the first FDA-approved clinical drug trial involving all-electronic home-based reporting. Trial participants will receive medication via the mail and use the mobile application to...